معرفی
Patrik Risteski is an EMBO Postdoctoral Fellow at the University of Oxford's Institute of Molecular Medicine (IMM), conducting research within the Chapman Group focused on recombination mechanisms in immunity and cancer.
Education:
- PhD
His research centers on molecular mechanisms of chromosome segregation during mitosis, specializing in microtubule dynamics, centrosome regulation, and cohesin-mediated centromere stabilization. Employing advanced microscopy techniques, his work investigates how errors in these processes drive genetic instability and cancer pathogenesis, with significant implications for therapeutic targeting of mitotic defects.
Recent publications (2022-2024) demonstrate consistent focus on mitotic machinery through high-impact studies in Nature, Cell, and PNAS, revealing novel mechanisms in poleward flux regulation, centromere architecture, and centrosome signaling pathways.
Awards:
- EMBO Postdoctoral Fellowship
As a postdoctoral researcher, Dr. Risteski currently has no documented advisees. His primary funding derives from the competitive EMBO fellowship supporting his chromosomal instability research.
He actively contributes to the Chapman Group's mission through experimental work on recombination mechanisms, utilizing the IMM's advanced cell biology infrastructure for cancer and immunity research.
